CRISPR Therapeutics AG CRSP
NASDAQ · United States · Health Technology
$55.69+0.37 (+0.67%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-03 | -0.94 | -1.19 | +21.3% | $10.18M | +36.7% | +10.6%$47.99→$53.07 |
| Q1 2026 | 2026-05-04 | -1.28 | -1.23 | -4.1% | — | — | +1.5%$51.63→$52.38 |
| Q4 2025 | 2026-02-12 | -1.37 | -1.23 | -11.4% | — | — | +9.8%$48.32→$53.07 |
| Q3 2025 | 2025-11-10 | -1.17 | -1.29 | +9.3% | — | — | +0.2%$55.12→$55.21 |
| Q2 2025 | 2025-08-04 | -1.29 | -1.40 | +7.9% | — | — | — |
| Q1 2025 | 2025-05-06 | -1.58 | -1.28 | -23.4% | — | — | — |
| Q4 2024 | 2025-02-11 | -0.44 | -1.19 | +63.0% | — | — | — |
| Q3 2024 | 2024-11-05 | -1.01 | -1.40 | +27.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.